Literature DB >> 14984356

Epidemiology of osteoarthritis in Australia.

Lynette M March1, Hanish Bagga.   

Abstract

Arthritis affects around 3 million people in Australia, representing about 15% of the population. Osteoarthritis is the leading cause of pain and disability among the elderly. Osteoarthritis is the third leading cause of life-years lost due to disability. Obesity and joint injury are important potentially modifiable risk factors for the development of osteoarthritis. Obesity is also an important predictor of progression of osteoarthritis. Currently, about 19000 hip and 20000 knee replacements are performed for osteoarthritis in Australia each year. Prevalence of osteoarthritis and the need for total joint replacement surgery are likely to increase because of a combination of increasing risk factors (age, obesity, injury), increasing expectations for improved quality of life, and improved surgical and anaesthetic techniques making surgery possible for more people. Services to provide these cost-effective procedures need to be increased. Primary and secondary prevention programs aimed at reducing obesity, preventing injury and improving rehabilitation and physical activity are urgently required.

Entities:  

Mesh:

Year:  2004        PMID: 14984356     DOI: 10.5694/j.1326-5377.2004.tb05906.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  47 in total

1.  Lower limb proprioception deficits persist following knee replacement surgery despite improvements in knee extension strength.

Authors:  Pazit Levinger; Hylton B Menz; Adam D Morrow; Elin Wee; Julian A Feller; John R Bartlett; Neil Bergman
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-10-18       Impact factor: 4.342

2.  A randomized controlled trial of chiropractic management of the lower limb kinetic chain for the treatment of hip osteoarthritis: a study protocol.

Authors:  Katie de Luca; Henry Pollard; James Brantingham; Gary Globe; Tammy Cassa
Journal:  J Chiropr Med       Date:  2011-04-05

3.  What has happened to people affected by thalidomide 50 years on?

Authors:  A O'Carroll; F O'Reilly; D L Whitford
Journal:  Ir J Med Sci       Date:  2011-02-03       Impact factor: 1.568

4.  Increase in Total Joint Arthroplasty Projected from 2014 to 2046 in Australia: A Conservative Local Model With International Implications.

Authors:  Maria C S Inacio; Stephen E Graves; Nicole L Pratt; Elizabeth E Roughead; Szilard Nemes
Journal:  Clin Orthop Relat Res       Date:  2017-05-09       Impact factor: 4.176

5.  Hospital discharge information after elective total hip or knee joint replacement surgery: A clinical audit of preferences among general practitioners.

Authors:  Andrew M Briggs; Nadia Lee; Moira Sim; Toby J Leys; Piers J Yates
Journal:  Australas Med J       Date:  2012-10-31

6.  Strategies for managing osteoarthritis.

Authors:  Norman Tiong Meng Ng; Kristiann C Heesch; Wendy J Brown
Journal:  Int J Behav Med       Date:  2012-09

7.  Do activity levels increase after total hip and knee arthroplasty?

Authors:  Paula Harding; Anne E Holland; Clare Delany; Rana S Hinman
Journal:  Clin Orthop Relat Res       Date:  2013-12-19       Impact factor: 4.176

Review 8.  Does low level laser therapy has effects on inflammatory biomarkers IL-1β, IL-6, TNF-α, and MMP-13 in osteoarthritis of rat models-a systemic review and meta-analysis.

Authors:  Gopal Nambi
Journal:  Lasers Med Sci       Date:  2020-08-24       Impact factor: 3.161

9.  A combined phase I and II open label study on the effects of a seaweed extract nutrient complex on osteoarthritis.

Authors:  Stephen P Myers; Joan O'Connor; J Helen Fitton; Lyndon Brooks; Margaret Rolfe; Paul Connellan; Hans Wohlmuth; Phil A Cheras; Carol Morris
Journal:  Biologics       Date:  2010-03-24

10.  Differences in gait patterns, pain, function and quality of life between males and females with knee osteoarthritis: a clinical trial.

Authors:  Ronen Debi; Amit Mor; Ofer Segal; Ganit Segal; Eytan Debbi; Gabriel Agar; Nahum Halperin; Amir Haim; Avi Elbaz
Journal:  BMC Musculoskelet Disord       Date:  2009-10-13       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.